Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Private sector revives the climate disaster database Trump tried to squash - 2HGV driver recruited others to smuggle migrants
- 3Sa'ar warns German delegation: 'A Palestinian state would be a Hamas terror state'
- 4Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
- 5France, Germany, Italy summon Iranian envoys over 'unbearable, inhumane' regime crackdown
- 2 of Earth's rarest lightning phenomena captured simultaneously in once-in-a-lifetime photo
- Tuesday, April 7. Russia’s War On Ukraine: News And Information From Ukraine
- At least 30 killed in attack on Nigeria village
- UN rights chief says Israeli policy in West Bank 'resembles apartheid system'
- Greece eyes migrant repatriation centres outside the EU
- Am I a Summer, or is this a scam? What I learned from color analysis.
- I read 115 books this year. 'Wuthering Heights,' 'Heart the Lover' and 'The House of My Mother' were among my 10 favorites.
- Sarkozy says he owes France 'the truth' as he challenges conviction over alleged Libya funding
- Artemis II astronauts will see parts of the moon no human has before. Here’s how
